|Product Name||MK-2866 / Ostarine / Enobosarm|
|Appearance||An odorless, almost white or white powder||pass|
|Identificaton||The retention time of the major peak is confirm to the RS||pass|
|Loss on Drying||Not more than 0.5%||0.33%|
|Assay(HPLC)||Not less than 99.0%||99.59%|
|Ignition residue||Not more than 0.1%||pass|
|Heavy metal||Not more than 20 ppm||pass|
Ostarine is the most anabolic of any SARMS, making its first and
foremost use for wanting to gain lean muscle. The gains in total
weight will not be comparable to bulking steroids, however the
total gains will almost entirely be lean muscle.
Ostarine would primarily fit into a cutting protocol for the
maintenance of muscle mass while reducing calories. One of the most
disheartening outcomes of cutting is the loss hard earned muscle
mass. The drop in metabolic rate and hormone levels (T3, etc) with
the lack of calories is a perfect catabolic environment for loss of
Recomping is where ostarine truly shines. The recomping effect of
losing fat and gaining muscle at the same time is what the majority
of users are looking for. Trying to achieve this when you are not
absolutely new to training is extremely difficult.
The effects of ostarine translate to anabolism in bone and skeletal
muscle tissue, which means it could be used in the future for a
variety of uses, such as osteoporosis and as a concurrent treatment
with drugs that reduce bone density. Therefore it has great
application as a compound to use for rehabilitation of injuries, in
particular bone and tendon related injuries.
As a SARM, Ostarine binds directly to the androgen receptors. While
anabolic steroids also bind to androgen receptors, SARM's cannot
convert to DHT or estrogen. Officially belonging to a group of
drugs, Ligand, MK 2866's only purpose is direct anabolic activity.
This SARM can be used for muscle growth or muscle preservation
Ostarine, like anabolic steroids, will increase protein synthesis
as well as nitrogen retention. However, unlike anabolic steroids,
it will do so without any DHTor estrogen conversion.
While no direct estrogen conversion is present in terms of
aromatase activity, mild increases in estrogen levels have been
shown. This is perhaps why Ostarine has been shown to be good for
joint health and healing. Estrogen often gets a bad wrap, but some
is needed for good health and physical performance. It is,however,
the direct binding to the receptor that is most important as it not
only promotes anabolism, it alters the gene sequence directly at
the receptor site; in fact, it is highly tissue specific, muscle
Recommended max dosage of Ostarine is around 25mg once a day for
men, and 12.5mg for females. It has a 24 hour half-life.
Lowest recommended aesthetic dose (meaning for physique
improvement) for males is 12.5mg. Lower doses will likely produce
very little results to be notice in terms or muscle gains, but will
help with join health.
Women's lowest recommended dose, for those seeking physique
improvement, is 5mg a day, and it should be noted that therapeutic
doses of as low as 3mg a day have been reported to be beneficial in
Benefits in bone and tendons have been reported at dosages as low
as 12.5 mg per day.
While preserving muscle gains and decreasing calories, MK-2866 can
help cut it off. Suggested dosing is 12.5-15mg for 4-6 weeks.
Shines best when used for gaining lean muscle (bulking) as it is
the most anabolic of all the SARMS. Suggested dosage is 25 mg for
4-6 weeks. PCT is not necessary. An increase of 6 lbs. of lean,
keepable gains can be observed during this period.
You can take Ostarine as high as 36 mg for 8 weeks BUT only if you
weigh 210 lbs. Suppression is expected in higher doses so PCT after
a cycle is a must.
Ostarine shines in recomping due to its nutrient portioning
results. Calorie is used to build muscle which helps in weight loss
and enhancing muscle mass and strength. Suggested dosing is 12.5-25
mg for 4-8 weeks.
Your diet must contain 30% of lean sources of protein to achieve
the best recomp result.
|AICAR||2627-69-2||acts by entering nucleoside pools, significantly increasing levels
of adenosine during periods of ATP breakdown|
|MK2866||841205-47-8||medical prescription for prevention of cachexia, atrophy, and
sarcopenia and for Hormone or Testoserone Replacement Therapy.|
|MK-677||15972-10-0||A growth hormone secretagogue, treatment of obesity, a promising
therapy for the treatment of frailty in the elderly|
|LGD-4033||1165910-22-4||pharmacological profile similar to that of enobosarm,
|GW501516||317318-70-0||For obesity, diabetes, dyslipidemia and cardiovascular disease|
|Andarine(S4)||401900-40-0||partial agonist, intended mainly for treatment of benign prostatic
|SR9009||1379686-30-2||under development at The Scripps Research Institute (TSRI),
increases the level of metabolic activity in skeletal muscles of
|SR9011||1379686-30-2||For obesity, diabetes, dyslipidemia and cardiovascular disease|
|RAD140||1182367-47-0||New generation for gaining mass and cutting edges|
|a SARM and myostatin inhibitor in one|
|GHRP-2||158861-67-7||Growth Hormone Releasing Peptide-2|
|GHRP-6||87616-84-0||Growth Hormone Releasing Peptide-6|
|TB500||107761-42-2||Thymosin beta 4|